MINI THARIAN: Open Payments
NPI 1770086191 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,086 in 40 payments from 15 companies in 2025. Trend: 2023 $885 · 2024 $1,041 · 2025 $1,086
Food & beverage: $1,086
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $273 |
| AstraZeneca Pharmaceuticals LP | 4 | $181 |
| Abbott Laboratories | 2 | $125 |
| Novartis Pharmaceuticals Corporation | 5 | $115 |
| Medtronic, Inc. | 2 | $79 |
| Merck Sharp & Dohme LLC | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| Kestra Medical Technology Services, Inc. | 2 | $36 |
| SCPHARMACEUTICALS INC. | 2 | $33 |
| ABIOMED | 1 | $30 |
Products named: JARDIANCE, CARDIOMEMS, LOKELMA, LEQVIO, VERQUVO, CAMZYOS, MICRA, WAINUA.
Industry payments across NY — which companies pay providers there.
